Skip directly to site content Skip directly to search


Español  Other Languages


An official website of the United States government Here's how you know
 Official icon**Official websites use .gov**
				A .gov website belongs to an official government organization in the United States. Lock icon**Secure .gov websites use HTTPS**
				A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
	CDC LogoCDC Logo
 Search

		×
			NIOSH
			NIOSH

				All CDC
				Submit


The National Institute for Occupational Safety and Health (NIOSH)





Current Intelligence Bulletin 4: Chrome Pigment						Print
																Related Pages
										October 8, 1976
DHHS (NIOSH) Publication Number 78-127
Department of Health, Education, and Welfare
Public Health Service
Center for Disease Control
National Institute for Occupational
Safety and Health
5600 Fishers Lane
Rockville, Maryland 20852
Dear Colleague:
A letter from the Lead Chromate Task Force of the Dry Color Manufacturers’ Association (DCMA), dated June 18, 1975, to NIOSH regarding recently published information associating lung carcinoma with exposure to chromate pigments Is attached for your review. The DCMA has already notified pigment manufacturers and their employees and customers of these findings. The result of epidemiologic investigation of chromate pigment production personnel and feeding studies in laboratory animals are expected from the DCMA later this year. Copies of the articles referred to in the letter from DCMA are available upon request from this office.
You will be kept apprised of future information as it becomes available.
Sincerely,
[*signature*]
J. William Lloyd, Sc.D., Director
Office of Occupational Health
Surveillance and Biometrics
E.I. Du Pont De Nemours & Company, Inc.
Wilimington, Delware 19898
Central Research & Development Department
Haskell Laboratory for Toxicology and Industrial Medicine
Mr. Edward J. Baier
Deputy Director
National Institute of Occupational Safety and Health
Public Health Service
Department of Health, Education, and Welfare
Danac Building
5600 Fishers Lane
Rockville, Maryland 20852
Dear Mr. Baier:
This letter is written on behalf of the Lead Chromate Task Force of the Dry Color Manufacturers’ Association. Earlier this year I had occasion to inform you of a program of investigation sponsored by the Dry Color Manufacturers’ Association which had as its intent an expansion of knowledge of the toxicity of lead chromate pigments and of any relationship that might exist between exposures to pigment dust and lung cancer. The program consists of a ninety-day feeding study with rats and dogs and an epidemiologic study in three manufacturing plants, two of which make lead chromate pigments and a third which makes lead chromate and zinc chromate pigments.
A final report on the feeding study will become available within a few week. The epidemiologic study is proceeding as scheduled and a final report will be available later this year.
It is the purpose of this letter to inform yon that member companies of the Dry Color Manufacturers’ Association have decided to notify employees in the manufacturing plants as follows:
Recently published research results suggest that excessive exposures to the dust of lead chromate pigments, lead-molybdenum chromate pigments, and zinc chromate pigments could have a relationship with causation of lung cancer;
the suggested relationship is under investigation by the means above described; and
the effort to control dust within the limits of the existing OSHA regulation will be continued.
It has been decided to send similar notification to pigments customers of the manufacturing companies.The recent publications which have prompted this decision at this time are:
Langard, Sverre and Tor Norseth. A Cohort Study of Bronchial Carcinomas in Workers Producing Chromate Pigments, Brit. Jour. Indus. Med. 32 62-65 (1975).
Maltoni, Cesare. Occupational Carcinogenesis International Congress Series No. 322 (ISBN 90 219 02281) Cancer Detection and Prevention, Proceedings of the Second International Symposium, Bologna, (April 1973).Another development was transmission privately of results from a series of pellet implant studies in rats with chromate materials at the Chester Beatty Institute in England.
The results of these studies singly or collectively are not regarded by DCMA as conclusive with respect to either lead chromate or zinc chromate. The results from the epidemiologic study of lead chromate workers are awaited before forming further judgment. These results will be sent to you as soon as possible. As you requested I am sending you herewith copies of the notifications that are being presented to employees (Item VI) and to customers (Item V). Attached also for your convenience are copies of the two recent publications.
Very truly yours,
[*signature*]
James F. Morgan
Consultant – Industrial Hygiene
JFM/egg
Department of Health, Education, and Welfare
Public Health Service
Center for Disease Control National Institute for Occupational Safety and Health 5600 Fishers Lane Rockville, Maryland 20852
Dear Colleague:
This is a further follow-up to information released by this office on June 24, 1975, concerning the potential carcinogenicity of chromate pigments.
On October 2, 1975, the Dry Color Manufacturers’ Association (DCMA) informed NIOSH of the progress of an epidemiologic study sponsored by the DCMA and presented some preliminary results from an analysis of mortality data collected to date. These preliminary results are based on an examination of the relative frequency of deaths from cancer and other causes among the first 38 deaths identified by the researchers in a group of 580 workers exposed to lead chromate. Lung cancer was the cause of death for nearly 29 percent of the deceased workers. This figure was contrasted with estimates from other industrial populations in which lung cancer represented 7 to 9 percent of all deaths. Further review of the data revealed that lung cancer deaths accounted for 85 percent of all cancer deaths. These preliminary findings suggest an unusually high lung cancer risk among workers exposed to lead chromate pigments.
You will be kept apprised of future information as it becomes available.
Sincerely yours,*[signature]*
J. William Lloyd, Sc.D., Director
Office of Occupational Health
and Biometrics
Lead Chromate – an Update
On July 7, 1976, the National Institute for Occupational Safety and Health (NIOSH) received the final report of a study of lead chromate workers sponsored by the Dry Color Manufacturers’ Association (DCMA). This report included final results of an epidemiologic study (preliminary results were reported by NIOSH in October 1975) along with the findings of an industrial hygiene study.
Prior to this, there have been limited reports (since 1940) of lung cancer among chrome pigment workers in Germany, Norway, and the United States. Studies of laboratory animals have indicated the potential for chrome pigments to produce tumors at the site of implantation or injection.
The study of lead chromate workers recently conducted for DCMA by Equitable Environmental Health, Inc., included three lead chromate plants in operation since the mid-1920’s, 1941, and 1949, respectively. Employees of two plants were found to have had only lead chromate exposures, while workers in the third plant (analyzed separately) also had zinc chromate exposure. The industrial hygiene study of the three plants showed that nearly one-half of the samples reached or exceeded OSHA standards for lead and chromium. (The standards in effect at the time of this study were: for lead, 0.2 mg/m3; for chromium, soluble chromic, or chromous salts, .5 mg/m3 as Cr; and for chromic acid or chromates, 0.1 mg/m3 as Cr03).
The levels of lead and chromium found in this study were assumed to be lower than levels in the past because of some process changes and modifications of engineering controls and work practices; however, this difference could not be quantitated because of changes in analytical methods.
The three-plant cohort analysis included a total of 548 men among whom 53 deaths had occurred prior to December 31, 1974. Standardized mortality ratios (SMRs) were determined by comparing the observed deaths due to major causes with the number of expected deaths based on the 1960 male population of the state in which each plant was located. For all employees in two plants (with only lead chromate exposure), a 3-fold excess of respiratory cancer was observed (SMR 313.7 compared with an expected 100. Workers employed prior to 1960 (allowing for a 15-year “latency” period) were analyzed separately. For all persons in this group, regardless of length of employment, the SMR for respiratory cancer was 173.5; for persons who were hired prior to 1960 and who had worked there for at least 10 years, this SMR was 236.4.
Employees of the third plant (with both lead and zinc chromate exposure) were all hired before 1960 and had an SMR of 237.1 for respiratory cancer. In addition, 5 deaths due to stomach cancer were observed; this was 7 times the expected number.
Although the small number of observed deaths did not justify statistical tests, the Equitable Environmental Health researchers agree that this apparent excess of respiratory cancer in lead chromate workers is “consistent with the hypothesis that lead chromate is a respiratory carcinogen.”
These findings are in accord with the NIOSH Criteria for a Recommended Standard on Hexavalent Chromium (December 1975) which states that lead chromate should be regarded as a human carcinogen.
[*signature*]
John F. Finklea, M.D.
Director
							
					
							Last Reviewed:  June 6, 2014						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Error processing SSI file  Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue